TG

Tanya Gershanik

VP, Quality Affairs at Protalix BioTherapeutics

Dr. Tanya (Tatyana) Gershanik joined Protalix in November 2011 and became the Vice President of Quality Affairs in September 2021.

Dr. Gershanik originally served as a Manager of the Quality Assurance department, and, for five years before her promotion to Vice President, Quality Affairs, as a Senior Director and Protalix’s Quality Person.

Prior to joining Protalix, Dr. Gershanik held a number of managerial positions in the pharmaceutical industry over a 12-year period, specifically in the fields of pharmaceutical technology and validation. She also served as a lecturer in the Master of Science program at the School of Pharmacy, Hebrew University of Jerusalem, at the QP Qualification program led by the School of Pharmacy, Hebrew University of Jerusalem, and at the Bioforum applied knowledge center.

Timeline

  • VP, Quality Affairs

    Current role